Langerhans cell histiocytosis: Retrospective evaluation of 123 patients at a single institution

Pediatric Hematology and Oncology

Volumn 16, Issue 5, 1999, Pages 377-385

  Braier, Jorge ^a   Chantada, Guillermo ^a   Rosso, Diego ^a   Bernaldez, Patricia ^a   Amaral, Diego ^a,c   Latella, Antonio ^a   Balancini, Blanca ^a   Masautis, Alicia ^b   Goldberg, Julio ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^b Biostatistics   (Argentina)

^c HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE   (Argentina)

Author keywords

Langerhans cell histiocytosis; Mortality; Prognostic factors; Retrospective evaluation; Sequelae

Indexed keywords

PREDNISONE; VINBLASTINE;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; CHILD; FOLLOW UP; HISTIOCYTOSIS; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LANGERHANS CELL; MAJOR CLINICAL STUDY; MORTALITY; NEWBORN; ORAL DRUG ADMINISTRATION; PROGNOSIS; SURVIVAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 0032819537     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199276921     Document Type: Article

References (26)

1. Lichtenstein L. Histiocytosis X: integration of eosinophilic granuloma of bone, Lettere Siwe disease and Schuller Christian disease as related manifestations of a single nosologic entity. Arch Pathol. 1953;56:84-102.
2. Nezelof C, Basset F, Rousseau MF. Histiocytosis X: histogenetic arguments for a Langerhans cell origin. Biomedicine. 1973;18:365-371.
3. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208-209.
4. Gadner H, Heitger A, Grois N, Gatterer-Menz I, Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:72-80.
5. Ladisch S, Gadner H, Aricó M, et al. LCH 1: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:107-110.
6. Lahey M. Histiocytosis X: an analysis of prognostic factors. J Pediatr. 1975;87:184-189.
7. Hosmer DW, Lemeshow S, eds. Applied Logistic Regression. New York: Wiley; 1989.
8. The French Langerhans Cell Histiocytosis Study Group. A multicentre retrospective survey of Langerhans cell histiocytosis: 348 cases observed between 1983 and 1993. Arch Dis Child. 1996;75:17-24.
9. Rivera Luna R, Alter Molchadsky N, Cardenas Cardós R, Martinez Guerra G. Langerhans cell histiocytosis in children under 2 years of age. Med Pediatr Oncol. 1996;26:334-343.
10. Raney R, D'Angio G. Langerhans cell histiocytosis (histiocytosis X): experience at the Children's Hospital of Philadelphia, 1970-1984. Med Pediatr Oncol. 1989;17:20-28.
11. Berry D, Gresik M, Humphrey G, et al. Natural history of histiocytosis X: a Pediatric Oncology Group Study. Med Pediatr Oncol. 1986;14:1-5.
12. Broadbent V, Pritchard J. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible? Med Pediatr Oncol. 1997;28:289-293.
13. Grois N, Flucher-Wolfram B, Heighter A, Mostbeck GH, Hofman J, Gadner H. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL HX 83 study. Med Pediatr Oncol. 1995;24:248-256.
14. Ceci A, de Terlizzi M, Colella R, et al. Langerhans cell histiocytosis in childhood: results from Italian Cooperative AEIOP-CNR-HX 83 study. Med Pediatr Oncol. 1993;21:259-264.
15. Grois N, Minkov M, Flucher Wolfram B, et al., for the LCH 1 Study Group. Liver involvement in multisystem Langerhans cell histiocytosis. Proc Twelfth Annual Meeting Histiocyte Society, Vienna, Austria; 1996.
16. Minkov M, Grois N, Flucher Wolfram B, Potschger V, Gadner H. Liver and pulmonary involvement i]n multisystem Langerhans cell histiocytosis. Proc Twelfth Annual Meeting Histiocyte Society, Vienna. Austria; 1996.
17. Braier J, Cuarterolo M, Chantada G, et al. Liver involvement in Langerhans cell histiocytosis. Med Pediatr Oncol. 1996;27:580.
18. Braier J, Chantada G, Rosso D, Grenoville M, Balancini B, Cuarterolo M. Visceral sequelae in LCH. Med Pediatr Oncol. 1997;28:162.
19. Concepción W, Esquivel C, Terry A, et al. Liver transplantation in Langerhans cell histiocytosis (histiocytosis X). Semin Oncol. 1991;18:24-28.
20. Sommerauer JF, Atkison P, Andrews W, Moore P, Wall W. Liver transplantation for Langerhans cell histiocytosis and immunomodulatton of disease pre- and posttransplant. Transplant Proc. 1994;26: 178-179.
21. Greenberger J, Crocker A, Vawter G, Jaffe N, Cassady JR. Results of treatment of 127 patients with systemic histiocytosis. Medicine. 1981;60:311-338.
22. Egeler R, Neglia J, Puccetti D, Brennan C, Nesbit M. Association of malignancy with Langerhans cell histiocytosis. Cancer. 1993;71:565-573.
23. Camargo B, Correa Alves A, Gorender B, Bianchi A. Association of malignancy and Langerhans cell histiocytosis: report of three cases. Med Pediatr Oncol. 1993;21:451-453.
24. Braier J, Fynn A, Balancini B, Drut R, Goldberg J. Unusual premalignant and malignant disease in LCH. Med Pediatr Oncol. 1997;28:164.
25. Sartoris DJ, Resnick D. Myelofibrosis arising in treated histiocytosis X. Eur J Pediatr. 1985;144:200-202.
26. Greinix HT, Storb B, Sanders J, Petersen F. Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis. Bone Marrow Transplant. 1992;10:39-44.